NUFORMIX
Nuformix has invested into pharmaceutical cocrystal R&D, establishing world-class capability and know-how in cocrystal discovery and development, yielding multiple product opportunities with an accompanying portfolio of intellectual property.
NUFORMIX
Industry:
Pharmaceutical
Founded:
2008-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.nuformix.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0)1223 423 667
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Ashbourne Pharmaceuticals
Ashbourne Pharmaceuticals distributes pharmaceutical products in the United Kingdom.
Funxional Therapeutics
Funxional Therapeutics develops pharmaceutical products focusing on the treatment of various diseases and disorders.
LipoLek
LipoLek develops pharmaceutical products based on the nanotechnology.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-09-15 | Levrett | Levrett acquired by Nuformix | 12 M GBP |
Official Site Inspections
http://www.nuformix.com Semrush global rank: 4.63 M Semrush visits lastest month: 2.15 K
- Host name: ec2-52-214-149-81.eu-west-1.compute.amazonaws.com
- IP address: 52.214.149.81
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Nuformix"
Nuformix - Crunchbase Company Profile & Funding
Nuformix develops pharmaceutical products using its cocrystal technology in the United Kingdom. Nuformix has invested into pharmaceutical cocrystal R&D, establishing world-class capability …See details»
Nuformix plc - AnnualReports.com
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. Its lead programs include NXP001, …See details»
NUFORMIX PLC overview - Find and update company information
NUFORMIX PLC - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activitySee details»
Nuformix Annual Report 2019 - Nuformix
Jul 28, 2020 · Nuformix Annual Report 2019. 28th July 2020. Download Document. Back to all DocumentsSee details»
Nuformix plc (“Nuformix”, the “Company” or the “Group”)
About Nuformix Nuformix is a pharmaceutical development company focused on unlocking the therapeutic potential and value of known drugs to develop novel medicines which provide …See details»
Nuformix Plc - LinkedIn
Unlocking the Potential of Therapeutics for Fibrosis & Oncology Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug …See details»
Nuformix plc: Shareholders, Shareholding Structure
2 days ago · Nuformix plc is a United Kingdom-based pharmaceutical development company. The Company is engaged in targeting unmet medical needs in fibrosis and oncology via drug …See details»
Nuformix PLC, NFX:LSE profile - FT.com - Financial Times
Nov 5, 2024 · Nuformix PLC (NFX:LSE) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Nuformix Company Profile 2024: Stock Performance & Earnings
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug …See details»
Nuformix Company Profile - Office Locations, Competitors ... - Craft
Nuformix (formerly known as Levrett) is a company that develops pharmaceutical products. The Company uses cocrystal technology. Its products include NXP001 for oncology supportive …See details»
Nuformix - Overview, News & Similar companies | ZoomInfo.com
Apr 14, 2020 · View Nuformix (www.nuformix.com) location in Greater London, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees …See details»
Our model - Nuformix
Nuformix early-stage pipeline of preclinical and Phase 1-ready assets has potential for significant value and early licensing opportunities Our business model is to take our assets to key value …See details»
Company Information - Nuformix plc (NFX) - Hargreaves Lansdown
Nov 5, 2024 · Nuformix plc is a United Kingdom-based pharmaceutical development company. The Company is engaged in targeting unmet medical needs in fibrosis and oncology via drug …See details»
Nuformix (LSE:NFX) - Stock Price, News & Analysis - Simply Wall St
4 days ago · Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has …See details»
Nuformix plc (NFX.L) Stock Price, News, Quote & History - Yahoo …
Find the latest Nuformix plc (NFX.L) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Company Nuformix plc - MarketScreener.com
Nuformix plc is a United Kingdom-based pharmaceutical development company. The Company is engaged in targeting unmet medical needs in fibrosis and oncology via drug repurposing.See details»
Nuformix plc: Governance, Directors and Executives & Committees ...
Mar 31, 2024 · Nuformix plc is a United Kingdom-based pharmaceutical development company. The Company is engaged in targeting unmet medical needs in fibrosis and oncology via drug …See details»
NFX Stock Price Quote - Morningstar
Nov 4, 2024 · See the latest Nuformix PLC stock price (NFX:XLON), related news, valuation, dividends and more to help you make your investing decisions.See details»
Expertise in repurposing and solid form science - Nuformix
We aim to use our expertise in solid form science to discover and file patent applications on new solid forms to facilitate development of alternative formulations and delivery methods to …See details»
VistaGen and Nuformix Announce Agreement to Develop Novel …
May 27, 2020 · Under the terms of the agreement, VistaGen and Nuformix initially will apply Nuformix's proprietary technology platform to develop patentable new crystalline forms of AV …See details»